期刊文献+

四联法抗幽门螺杆菌感染疗效分析 被引量:3

Analysis of the effect of tetrad therapy for helicobacter pylori
下载PDF
导出
摘要 目的:探讨四联法抗幽门螺杆菌(Hp)的药物疗效。方法:对本中心14C呼气实验阳性的患者100例进行泮托拉唑、阿莫西林克拉维酸钾、呋喃唑酮和胶体果胶铋四联抗Hp治疗,对疗效进行回顾性分析。结果:经过治疗,100例患者中根除了Hp 93例,Hp根除率达到97%。结论:四联法抗Hp疗效显著。 Objective:To evaluate the effect of tetrad therapy for helicobacter pylori.Methods:We have treated 100 patients who are positive in 14C exhalation experiment with pantoprazole,amoxicillin clavulanate potassium,furazolidone and colloidal bismuth.Then we evaluated the effect of tetrad therapy for helicobacter pylori.Results:93 cases of the 100 patients were eradicated of helicobacter pylori.The eradication rate of Hp reached 97%.Conclusion:The tetrad therapy is effective in treatment of helicobacter pylori.
作者 武绍梅 郑苏云 秦仲周 汤金莲 田会云 杨丽红 保雪东 Wu Shaomei;Zheng Suyun;Qin Zhongzhou;Tang Jinlian;Tian Huiyun;Yang Lihong;Bao Xuedong(Digestive endoscopy center of the First People's Hospital of Qujing City,Yunnan Province 655000)
出处 《中国社区医师》 2019年第10期76-76,共1页 Chinese Community Doctors
关键词 幽门螺杆菌 呋喃唑酮 胶体果胶铋 泮托拉唑 阿莫西林克拉维酸钾 Helicobacter pylori Furazolidone Colloidal bismuth Pantoprazole Amoxicillin clavulanate potassium
  • 相关文献

参考文献4

二级参考文献50

  • 1Qin-Juan Sun, Xiao Liang, Qing Zheng, Wei-Qi Gu, WenZhong Liu, Shu-Dong Xiao, Hong Lu.Resistance of Helicobacter pylori to antibiotics from 2000 to 2009 in Shanghai[J].World Journal of Gastroenterology,2010,16(40):5118-5121. 被引量:91
  • 2成虹,胡伏莲,谢勇,胡品津,王吉耀,吕农华,张建中,张桂英,周曾芬,吴克利,张玲霞,彭孝伟,戴宁,唐国都,姜葵,李岩,侯晓华,白文元,王明春,叶红军,刘玉兰,许乐.中国幽门螺杆菌耐药状况以及耐药对治疗的影响—全国多中心临床研究[J].胃肠病学,2007,12(9):525-530. 被引量:518
  • 3Noauthors listed.Unidentified curved bacilli on gastric epithelium in active chronic gastritis[J].Lancet,1983;1(8336):1273-5.
  • 4Eid R,Moss SF.Helicobacter pylori infection and the development of gastric cancer[J].N Engl J Med,2002;346(1):65-7.
  • 5Graham DY,Fischbach L.Helicobacter pylori infection[J].N Engl JMed,2010;363(6):595-6.
  • 6Malfertheiner P,Megraud F,O'Morain CA,et al.Management of Helicobacter pylori infection--the MaastrichtⅣ/Florence Consensus Repor[J].Gut,2012;61(5):646-64.
  • 7Gisbert JP,Mcnicholl AG.Maintenance of Helicobacter pylori eradication rates with triple therapy over 12 years in a Spanish hospital[J].Helicobacter,2012;17(2):160-1.
  • 8Graham DY,Fischbach L.Helicobacter pylori treatment in the era of increasing antibiotic resistance[J].Gut,2010;59(8):1143-53.
  • 9Malfertheiner P,Bazzoli F,Delchier JC,et al.Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium,metronidazole,and tetracycline given with omeprazole versus clarithromycinbased triple therapy:a randomised,open-label,non-inferiority,phase 3tria[J].Lancet,2011;377(9769):905-13.
  • 10Malfertheiner P,Megraud F,O'Morain C,et al.Current concepts in the management of Helicobacter pylori infection:the MaastrichtⅢConsensus Repor[J].Gut,2007;56(6):772-81.

共引文献40

同被引文献25

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部